Brought to you by 
Genesis and Stanford Rook team up to develop asthma vaccine
04 Jun 1999
Executive Summary
Genesis Research (New Zealand genomics firm focused on immune disorders) and Stanford Rook (UK vaccine company ) will combine their complementary technologies involving mycobacterium vaccae to co-develop an asthma vaccine.
Deal Industry
-
Pharmaceuticals
- Vaccines
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Genesis and Stanford Rook team up to develop asthma vaccine
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice